Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Omega Healthcare Investors Inc has a consensus price target of $36.11 based on the ratings of 21 analysts. The high is $45 issued by BMO Capital on December 9, 2024. The low is $25 issued by Credit Suisse on March 31, 2023. The 3 most-recent analyst ratings were released by Truist Securities, Wells Fargo, and BMO Capital on March 18, 2025, March 10, 2025, and December 9, 2024, respectively. With an average price target of $41.67 between Truist Securities, Wells Fargo, and BMO Capital, there's an implied 11.11% upside for Omega Healthcare Investors Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/18/2025 | Buy Now | 4% | Truist Securities | Michael Lewis70% | $38 → $39 | Maintains | Hold | Get Alert |
03/10/2025 | Buy Now | 9.33% | Wells Fargo | John Kilichowski44% | $43 → $41 | Maintains | Overweight | Get Alert |
02/07/2025 | Buy Now | — | JMP Securities | Aaron Hecht59% | — | Reiterates | Market Perform → Market Perform | Get Alert |
12/09/2024 | Buy Now | 20% | BMO Capital | Juan Sanabria58% | $45 → $45 | Upgrade | Market Perform → Outperform | Get Alert |
12/05/2024 | Buy Now | -1.33% | Mizuho | Haendel St. Juste57% | $35 → $37 | Maintains | Neutral | Get Alert |
11/11/2024 | Buy Now | 14.67% | RBC Capital | Michael Carroll64% | $39 → $43 | Maintains | Sector Perform | Get Alert |
10/18/2024 | Buy Now | 20% | Berenberg | Kai Klose12% | → $45 | Initiates | → Buy | Get Alert |
10/07/2024 | Buy Now | 20% | BMO Capital | Juan Sanabria58% | $44 → $45 | Maintains | Market Perform | Get Alert |
10/01/2024 | Buy Now | 14.67% | Wells Fargo | Connor Siversky67% | $40 → $43 | Assumes | Overweight → Overweight | Get Alert |
09/04/2024 | Buy Now | 4% | Truist Securities | Michael Lewis70% | $33 → $39 | Maintains | Hold | Get Alert |
08/26/2024 | Buy Now | 4% | Scotiabank | Nicholas Yulico55% | $33 → $39 | Maintains | Sector Perform | Get Alert |
07/09/2024 | Buy Now | -12% | Scotiabank | Nicholas Yulico55% | $32 → $33 | Maintains | Sector Perform | Get Alert |
06/26/2024 | Buy Now | -12% | Truist Securities | Michael Lewis70% | $32 → $33 | Maintains | Hold | Get Alert |
05/06/2024 | Buy Now | — | JMP Securities | Aaron Hecht59% | — | Reiterates | → Market Perform | Get Alert |
04/02/2024 | Buy Now | -14.67% | Truist Securities | Michael Lewis70% | $31 → $32 | Maintains | Hold | Get Alert |
03/22/2024 | Buy Now | -6.67% | Citigroup | Nicholas Joseph45% | $32 → $35 | Upgrade | Neutral → Buy | Get Alert |
02/26/2024 | Buy Now | -6.67% | Wells Fargo | Connor Siversky67% | $31 → $35 | Upgrade | Equal-Weight → Overweight | Get Alert |
02/08/2024 | Buy Now | -20% | Exane BNP Paribas | Nate Crossett53% | → $30 | Upgrade | Underperform → Neutral | Get Alert |
01/30/2024 | Buy Now | -4% | Deutsche Bank | Omotayo Okusanya63% | → $36 | Initiates | → Buy | Get Alert |
01/16/2024 | Buy Now | -17.33% | B of A Securities | Joshua Dennerlein49% | $33 → $31 | Downgrade | Buy → Neutral | Get Alert |
01/03/2024 | Buy Now | -9.33% | Mizuho | Haendel St. Juste57% | $35 → $34 | Maintains | Buy | Get Alert |
12/26/2023 | Buy Now | -17.33% | Truist Securities | Michael Lewis70% | $34 → $31 | Maintains | Hold | Get Alert |
11/27/2023 | Buy Now | -12% | Wells Fargo | Connor Siversky67% | $34 → $33 | Maintains | Equal-Weight | Get Alert |
11/06/2023 | Buy Now | — | Exane BNP Paribas | Nate Crossett53% | — | Downgrade | Neutral → Underperform | Get Alert |
10/17/2023 | Buy Now | -9.33% | Wells Fargo | Connor Siversky67% | $33 → $34 | Maintains | Equal-Weight | Get Alert |
10/11/2023 | Buy Now | — | Exane BNP Paribas | Nate Crossett53% | — | Initiates | → Neutral | Get Alert |
10/10/2023 | Buy Now | -4% | B of A Securities | Joshua Dennerlein49% | → $36 | Upgrade | Neutral → Buy | Get Alert |
10/03/2023 | Buy Now | -9.33% | Wedbush | Richard Anderson64% | → $34 | Initiates | → Neutral | Get Alert |
09/27/2023 | Buy Now | -9.33% | Truist Securities | Michael Lewis70% | $33 → $34 | Maintains | Hold | Get Alert |
09/20/2023 | Buy Now | -4% | Raymond James | Jonathan Hughes65% | $33 → $36 | Maintains | Outperform | Get Alert |
09/12/2023 | Buy Now | -12% | RBC Capital | Michael Carroll64% | → $33 | Initiates | → Sector Perform | Get Alert |
09/08/2023 | Buy Now | -6.67% | Mizuho | Haendel St. Juste57% | $31 → $35 | Upgrade | Neutral → Buy | Get Alert |
08/07/2023 | Buy Now | -12% | Wells Fargo | Connor Siversky67% | $32 → $33 | Maintains | Equal-Weight | Get Alert |
07/27/2023 | Buy Now | -6.67% | Berenberg | Tao Qiu45% | → $35 | Reinstates | → Buy | Get Alert |
07/27/2023 | Buy Now | -8% | BMO Capital | Juan Sanabria58% | → $34.5 | Initiates | → Market Perform | Get Alert |
07/26/2023 | Buy Now | -14.67% | Wells Fargo | Connor Siversky67% | → $32 | Downgrade | Overweight → Equal-Weight | Get Alert |
06/21/2023 | Buy Now | -12% | Truist Securities | Michael Lewis70% | $29 → $33 | Maintains | Hold | Get Alert |
05/30/2023 | Buy Now | -17.33% | Mizuho | Haendel St. Juste57% | $32 → $31 | Maintains | Neutral | Get Alert |
05/11/2023 | Buy Now | -14.67% | Wells Fargo | Connor Siversky67% | $30 → $32 | Maintains | Overweight | Get Alert |
05/03/2023 | Buy Now | -12% | Stifel | Stephen Manaker44% | $36 → $33 | Maintains | Buy | Get Alert |
04/20/2023 | Buy Now | -20% | Wells Fargo | Connor Siversky67% | → $30 | Initiates | → Overweight | Get Alert |
04/19/2023 | Buy Now | — | Wells Fargo | Connor Siversky67% | — | Initiates | → Overweight | Get Alert |
03/31/2023 | Buy Now | -33.33% | Credit Suisse | Omotayo Okusanya63% | → $25 | Reiterates | → Underperform | Get Alert |
02/22/2023 | Buy Now | -25.33% | Citigroup | Nicholas Joseph45% | $30 → $28 | Maintains | Neutral | Get Alert |
02/15/2023 | Buy Now | -12% | Raymond James | Jonathan Hughes65% | $35 → $33 | Maintains | Outperform | Get Alert |
01/17/2023 | Buy Now | -17.33% | Barclays | Steve Valiquette53% | $33 → $31 | Maintains | Equal-Weight | Get Alert |
01/09/2023 | Buy Now | -33.33% | Credit Suisse | Omotayo Okusanya63% | → $25 | Downgrade | Neutral → Underperform | Get Alert |
11/14/2022 | Buy Now | -12% | B of A Securities | Joshua Dennerlein49% | $35 → $33 | Downgrade | Buy → Neutral | Get Alert |
11/09/2022 | Buy Now | -6.67% | Raymond James | Jonathan Hughes65% | $34 → $35 | Maintains | Outperform | Get Alert |
10/10/2022 | Buy Now | — | Baird | Amanda Sweitzer44% | — | Downgrade | Outperform → Neutral | Get Alert |
09/13/2022 | Buy Now | -9.33% | Truist Securities | Michael Lewis70% | $30 → $34 | Maintains | Hold | Get Alert |
08/05/2022 | Buy Now | -6.67% | B of A Securities | Joshua Dennerlein49% | $27 → $35 | Upgrade | Underperform → Buy | Get Alert |
08/03/2022 | Buy Now | -9.33% | Raymond James | Jonathan Hughes65% | $33 → $34 | Maintains | Outperform | Get Alert |
06/30/2022 | Buy Now | -25.33% | Jefferies | Jonathan Petersen60% | $32 → $28 | Downgrade | Buy → Hold | Get Alert |
06/14/2022 | Buy Now | -20% | Truist Securities | Michael Lewis70% | $33 → $30 | Maintains | Hold | Get Alert |
04/26/2022 | Buy Now | -22.67% | Barclays | Steve Valiquette53% | → $29 | Initiates | → Equal-Weight | Get Alert |
The latest price target for Omega Healthcare Invts (NYSE:OHI) was reported by Truist Securities on March 18, 2025. The analyst firm set a price target for $39.00 expecting OHI to rise to within 12 months (a possible 4.00% upside). 15 analyst firms have reported ratings in the last year.
The latest analyst rating for Omega Healthcare Invts (NYSE:OHI) was provided by Truist Securities, and Omega Healthcare Invts maintained their hold rating.
The last upgrade for Omega Healthcare Investors Inc happened on December 9, 2024 when BMO Capital raised their price target to $45. BMO Capital previously had a market perform for Omega Healthcare Investors Inc.
The last downgrade for Omega Healthcare Investors Inc happened on January 16, 2024 when B of A Securities changed their price target from $33 to $31 for Omega Healthcare Investors Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Omega Healthcare Invts, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Omega Healthcare Invts was filed on March 18, 2025 so you should expect the next rating to be made available sometime around March 18, 2026.
While ratings are subjective and will change, the latest Omega Healthcare Invts (OHI) rating was a maintained with a price target of $38.00 to $39.00. The current price Omega Healthcare Invts (OHI) is trading at is $37.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.